VIOLIN Logo
VO Banner
Search: for Help
Protegen Home
Introduction
Statistics
News and Updates
Protegen Query
Protegen BLAST
Selected Bacteria
Brucella spp. (26)
B. anthracis (14)
E. coli (40)
M. tuberculosis (28)
N. meningitidis (18)
Selected Viruses
Ebola virus (19)
HIV (41)
Influenza virus (50)
Selected Parasites
Plasmodium (47)
Data Submission
Data Exchange
Data Download
Documentation
FAQs
Disclaimer
Contact Us
UMMS Logo


F1-ATPase

General Information
Protegen ID 564
Sequence Strain (Species/Organism) Leishmania donovani
VO ID VO_0011154
Taxonomy ID 5661
Other Database IDs CDD:304359
CDD:238540
CDD:278722
Molecule Role Protective antigen
Molecule Role Annotation Study compared the vaccine efficacy of various L. donovani antigens encapsulated in cationic liposomes in BALB/c mice against challenge infection with L. donovani. Results demonstrated that liposomal LD31 (ATP synthase alpha chain) reduced parasite burden by 74%-77% (Bhowmick and Ali, 2009).
Related Vaccines(s) L. donovani LD31 Protein Vaccine
References
Bhowmick and Ali, 2009: Bhowmick S, Ali N. Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis. PloS one. 2009; 4(6); e5820. [PubMed: 19503834].
Gene Information
Gene Name F1-ATPase
Protein Information
Protein Name F1-ATPase beta subunit
NCBI Protein GI 722242
Protein pI 4.18
Protein Weight 20953.9
Protein Length 292
Protein Note promastigotes of Leishmania donovani Sudan 1S maintained in liquid culture as a suspension
Protein Sequence
>AAA73465.1 F1-ATPase beta subunit, partial (mitochondrion) [Leishmania donovani]
KVALVYGQMNEPPGARAGVAESAVTMAEYFRDVEGQNVLLFIDNIFRFTQANSEVSALLGRIPAAVGYQP
TLAEDLGMLQERITSTTKGSITSVQAVYVPADDITDPAPATTFSHLDATTVLDRAVAESGIYPAVNPLEC
ASRIMDPDVIDVDHYNVAQDIVQMLTKYKELQDIIAVLGIDELSEEDKVVVDRARKVTRFLSQPFQ

Epitope Information
IEDB Linear Epitope